Skip to main content
European Commission logo print header

Praziquantel: its central role in the chemotherapy of schistosome infection

Objetivo

This proposal will be centred on aspects of praziquantel usage and will involve a group of scientists from disease endemic countries (with a major focus on Africa). They will be linked with a group of scientists from European Member States who share their common interest in researching the clinical, biological, epidemiological , pharmacological and socio-economic aspects of praziquantel use for the control of schistosome infection and disease. The Concerted Action will provide rational answers to questions related to the use of praziquantel in order to arm national health authorities and international agencies with appropriate information to ensure implementation of effective control programmes using praziquantel . The project will provide methodological tools to deal with any outbreak of drug resistant parasites and will develop strategies that if implemented will reduce the likelihood of emergence of drug resistant parasites

Tema(s)

Data not available

Convocatoria de propuestas

Data not available

Coordinador

UNIVERSITY OF GLASGOW
Aportación de la UE
Sin datos
Dirección
University Avenue, Joseph Black Building
G12 8QQ GLASGOW
Reino Unido

Ver en el mapa

Coste total
Sin datos

Participantes (20)